Lipocine Inc.LPCNNASDAQ
Loading
Year-over-year book value per share growth
Latest
1.70%
↑ 143% vs avg
Percentile
P79
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-3.91%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 1.70% |
| Q3 2025 | -18.37% |
| Q2 2025 | -10.85% |
| Q1 2025 | -8.72% |
| Q4 2024 | 10.02% |
| Q3 2024 | -9.93% |
| Q2 2024 | -11.94% |
| Q1 2024 | 16.99% |
| Q4 2023 | -10.33% |
| Q3 2023 | -21.84% |
| Q2 2023 | -12.20% |
| Q1 2023 | -9.29% |
| Q4 2022 | -15.24% |
| Q3 2022 | -12.06% |
| Q2 2022 | 13.41% |
| Q1 2022 | -6.94% |
| Q4 2021 | 21.06% |
| Q3 2021 | 2.78% |
| Q2 2021 | -19.89% |
| Q1 2021 | 124.92% |
| Q4 2020 | -2.24% |
| Q3 2020 | -11.83% |
| Q2 2020 | 67.99% |
| Q1 2020 | -22.57% |
| Q4 2019 | -31.85% |
| Q3 2019 | -25.05% |
| Q2 2019 | -26.24% |
| Q1 2019 | 24.39% |
| Q4 2018 | -23.67% |
| Q3 2018 | -12.06% |
| Q2 2018 | -18.09% |
| Q1 2018 | -10.96% |
| Q4 2017 | -21.36% |
| Q3 2017 | -12.34% |
| Q2 2017 | -2.44% |
| Q1 2017 | -6.53% |
| Q4 2016 | -8.56% |
| Q3 2016 | -8.91% |
| Q2 2016 | -12.82% |
| Q1 2016 | -14.70% |